Literature DB >> 8740566

The clinical interface--a British physician's view.

J Neuberger1, M Peters.   

Abstract

There appears to be a growing divergence, in the UK, between the hospital clinician and laboratory specialist as to their respective roles in the investigation of patients. The clinician requires a prompt service based on effective communication systems and rapid turnaround of test results. Laboratory specialists generally perceive both their role and that of the laboratory as consultative, often imposing barriers in order to give efficient patient care and maintain efficient use of resources. In order that greatest use of the laboratory service can be achieved in the United Kingdom, guidelines relating to appropriate and effective laboratory investigation should be agreed between clinicians and laboratory specialists and further studies undertaken to characterise the effects on outcome measures such as patient bed-stay, of the availability of test data and consultant opinion. The strong tradition of mutual respect and understanding between the two disciplines should not be jeopardised by the view of the clinician, who has the responsibility of diagnosing and managing the patient, that the laboratories are there to provide a service. Improved communication, both verbal and electronic, is required to reposition laboratory services within a rapidly changing health service.

Entities:  

Mesh:

Year:  1996        PMID: 8740566     DOI: 10.1016/0009-8981(95)06262-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Laboratory turnaround time.

Authors:  Robert C Hawkins
Journal:  Clin Biochem Rev       Date:  2007-11

2.  LabPush: a pilot study of providing remote clinics with laboratory results via short message service (SMS) in Swaziland, Africa.

Authors:  Wen-Shan Jian; Min-Huei Hsu; Hosea Sukati; Shabbir Syed-Abdul; Jeremiah Scholl; Nduduzo Dube; Chun-Kung Hsu; Tai-jung Wu; Vera Lin; Tex Chi; Peter Chang; Yu-Chuan Li
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.